Aneuploidy with neural tube defects

Another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein

Arie Drugan, Mark Paul Johnson, Elaina Dvorin, Joyce Moody, Eric L. Krivchenia, David Schwartz, Mark I. Evans

Research output: Contribution to journalArticle

Abstract

Some recent reports have suggested that invasive testing is unnecessary when ultrasound either confirms or refutes a neural tube defect (NTD). However, counseling for recurrence risks and the possibilities for in utero therapy would be significantly altered by an aneuplotd karyotype. We report our experience with 53 pregnancies affected by NTD in which we found 13.2% of these fetuses with abnormal chromosomes. In view of the higher than previously published incidence of aneuploidy, we believe that fetal karyotypes are essential in the evaluation of all fetuses with NTDs.

Original languageEnglish (US)
Pages (from-to)88-92
Number of pages5
JournalFetal Diagnosis and Therapy
Volume4
Issue number2-3
DOIs
StatePublished - 1989
Externally publishedYes

Fingerprint

Neural Tube Defects
alpha-Fetoproteins
Aneuploidy
Karyotype
Fetus
Mothers
Serum
Counseling
Chromosomes
Recurrence
Pregnancy
Incidence
Therapeutics

Keywords

  • Aneuploidy
  • Neural tube defects
  • α-Fetoprotein

ASJC Scopus subject areas

  • Embryology
  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health
  • Radiology Nuclear Medicine and imaging

Cite this

Aneuploidy with neural tube defects : Another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein. / Drugan, Arie; Johnson, Mark Paul; Dvorin, Elaina; Moody, Joyce; Krivchenia, Eric L.; Schwartz, David; Evans, Mark I.

In: Fetal Diagnosis and Therapy, Vol. 4, No. 2-3, 1989, p. 88-92.

Research output: Contribution to journalArticle

Drugan, Arie ; Johnson, Mark Paul ; Dvorin, Elaina ; Moody, Joyce ; Krivchenia, Eric L. ; Schwartz, David ; Evans, Mark I. / Aneuploidy with neural tube defects : Another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein. In: Fetal Diagnosis and Therapy. 1989 ; Vol. 4, No. 2-3. pp. 88-92.
@article{eb444c01de4f45fdac34c947ebc7a803,
title = "Aneuploidy with neural tube defects: Another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein",
abstract = "Some recent reports have suggested that invasive testing is unnecessary when ultrasound either confirms or refutes a neural tube defect (NTD). However, counseling for recurrence risks and the possibilities for in utero therapy would be significantly altered by an aneuplotd karyotype. We report our experience with 53 pregnancies affected by NTD in which we found 13.2{\%} of these fetuses with abnormal chromosomes. In view of the higher than previously published incidence of aneuploidy, we believe that fetal karyotypes are essential in the evaluation of all fetuses with NTDs.",
keywords = "Aneuploidy, Neural tube defects, α-Fetoprotein",
author = "Arie Drugan and Johnson, {Mark Paul} and Elaina Dvorin and Joyce Moody and Krivchenia, {Eric L.} and David Schwartz and Evans, {Mark I.}",
year = "1989",
doi = "10.1159/000263429",
language = "English (US)",
volume = "4",
pages = "88--92",
journal = "Fetal Diagnosis and Therapy",
issn = "1015-3837",
publisher = "S. Karger AG",
number = "2-3",

}

TY - JOUR

T1 - Aneuploidy with neural tube defects

T2 - Another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein

AU - Drugan, Arie

AU - Johnson, Mark Paul

AU - Dvorin, Elaina

AU - Moody, Joyce

AU - Krivchenia, Eric L.

AU - Schwartz, David

AU - Evans, Mark I.

PY - 1989

Y1 - 1989

N2 - Some recent reports have suggested that invasive testing is unnecessary when ultrasound either confirms or refutes a neural tube defect (NTD). However, counseling for recurrence risks and the possibilities for in utero therapy would be significantly altered by an aneuplotd karyotype. We report our experience with 53 pregnancies affected by NTD in which we found 13.2% of these fetuses with abnormal chromosomes. In view of the higher than previously published incidence of aneuploidy, we believe that fetal karyotypes are essential in the evaluation of all fetuses with NTDs.

AB - Some recent reports have suggested that invasive testing is unnecessary when ultrasound either confirms or refutes a neural tube defect (NTD). However, counseling for recurrence risks and the possibilities for in utero therapy would be significantly altered by an aneuplotd karyotype. We report our experience with 53 pregnancies affected by NTD in which we found 13.2% of these fetuses with abnormal chromosomes. In view of the higher than previously published incidence of aneuploidy, we believe that fetal karyotypes are essential in the evaluation of all fetuses with NTDs.

KW - Aneuploidy

KW - Neural tube defects

KW - α-Fetoprotein

UR - http://www.scopus.com/inward/record.url?scp=84940127026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940127026&partnerID=8YFLogxK

U2 - 10.1159/000263429

DO - 10.1159/000263429

M3 - Article

VL - 4

SP - 88

EP - 92

JO - Fetal Diagnosis and Therapy

JF - Fetal Diagnosis and Therapy

SN - 1015-3837

IS - 2-3

ER -